Cargando…
SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells
The downregulation of tight junction protein CLDN6 promotes breast cancer cell migration and invasion; however, the exact mechanism underlying CLDN6 downregulation remains unclear. CLDN6 silence is associated with DNA methyltransferase 1 (DNMT1) mediated DNA methylation, and DNMT1 is regulated by th...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618512/ https://www.ncbi.nlm.nih.gov/pubmed/28867761 http://dx.doi.org/10.3390/ijms18091863 |
_version_ | 1783267203431268352 |
---|---|
author | Lu, Yan Wang, Liping Li, Hairi Li, Yanru Ruan, Yang Lin, Dongjing Yang, Minlan Jin, Xiangshu Guo, Yantong Zhang, Xiaoli Quan, Chengshi |
author_facet | Lu, Yan Wang, Liping Li, Hairi Li, Yanru Ruan, Yang Lin, Dongjing Yang, Minlan Jin, Xiangshu Guo, Yantong Zhang, Xiaoli Quan, Chengshi |
author_sort | Lu, Yan |
collection | PubMed |
description | The downregulation of tight junction protein CLDN6 promotes breast cancer cell migration and invasion; however, the exact mechanism underlying CLDN6 downregulation remains unclear. CLDN6 silence is associated with DNA methyltransferase 1 (DNMT1) mediated DNA methylation, and DNMT1 is regulated by the transforming growth factor beta (TGFβ)/SMAD pathway. Therefore, we hypothesized that TGFβ/SMAD pathway, specifically SMAD2, may play a critical role for CLDN6 downregulation through DNA methyltransferase 1 (DNMT1) mediated DNA methylation. To test this hypothesis, we blocked the SMAD2 pathway with SB431542 in two human breast cancer cell lines (MCF-7 and SKBR-3). Our results showed that treatment with SB431542 led to a decrease of DNMT1 expression and the binding activity for CLDN6 promoter. The methylation level of CLDN6 promoter was decreased, and simultaneously CLDN6 protein expression increased. Upregulation of CLDN6 inhibited epithelial to mesenchymal transition (EMT) and reduced the migration and invasion ability of both MCF-7 and SKBR-3 cells. Furthermore, knocked down of CLDN6 abolished SB431542 effects on suppression of EMT associated gene expression and inhibition of migration and invasion. Thus, we demonstrated that the downregulation of CLDN6 is regulated through promoter methylation by DNMT1, which depends on the SMAD2 pathway, and that CLDN6 is a key regulator in the SMAD2/DNMT1/CLDN6 pathway to inhibit EMT, migration and invasion of breast cancer cells. |
format | Online Article Text |
id | pubmed-5618512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56185122017-09-30 SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells Lu, Yan Wang, Liping Li, Hairi Li, Yanru Ruan, Yang Lin, Dongjing Yang, Minlan Jin, Xiangshu Guo, Yantong Zhang, Xiaoli Quan, Chengshi Int J Mol Sci Article The downregulation of tight junction protein CLDN6 promotes breast cancer cell migration and invasion; however, the exact mechanism underlying CLDN6 downregulation remains unclear. CLDN6 silence is associated with DNA methyltransferase 1 (DNMT1) mediated DNA methylation, and DNMT1 is regulated by the transforming growth factor beta (TGFβ)/SMAD pathway. Therefore, we hypothesized that TGFβ/SMAD pathway, specifically SMAD2, may play a critical role for CLDN6 downregulation through DNA methyltransferase 1 (DNMT1) mediated DNA methylation. To test this hypothesis, we blocked the SMAD2 pathway with SB431542 in two human breast cancer cell lines (MCF-7 and SKBR-3). Our results showed that treatment with SB431542 led to a decrease of DNMT1 expression and the binding activity for CLDN6 promoter. The methylation level of CLDN6 promoter was decreased, and simultaneously CLDN6 protein expression increased. Upregulation of CLDN6 inhibited epithelial to mesenchymal transition (EMT) and reduced the migration and invasion ability of both MCF-7 and SKBR-3 cells. Furthermore, knocked down of CLDN6 abolished SB431542 effects on suppression of EMT associated gene expression and inhibition of migration and invasion. Thus, we demonstrated that the downregulation of CLDN6 is regulated through promoter methylation by DNMT1, which depends on the SMAD2 pathway, and that CLDN6 is a key regulator in the SMAD2/DNMT1/CLDN6 pathway to inhibit EMT, migration and invasion of breast cancer cells. MDPI 2017-08-30 /pmc/articles/PMC5618512/ /pubmed/28867761 http://dx.doi.org/10.3390/ijms18091863 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, Yan Wang, Liping Li, Hairi Li, Yanru Ruan, Yang Lin, Dongjing Yang, Minlan Jin, Xiangshu Guo, Yantong Zhang, Xiaoli Quan, Chengshi SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells |
title | SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells |
title_full | SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells |
title_fullStr | SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells |
title_full_unstemmed | SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells |
title_short | SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells |
title_sort | smad2 inactivation inhibits cldn6 methylation to suppress migration and invasion of breast cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618512/ https://www.ncbi.nlm.nih.gov/pubmed/28867761 http://dx.doi.org/10.3390/ijms18091863 |
work_keys_str_mv | AT luyan smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT wangliping smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT lihairi smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT liyanru smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT ruanyang smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT lindongjing smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT yangminlan smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT jinxiangshu smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT guoyantong smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT zhangxiaoli smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells AT quanchengshi smad2inactivationinhibitscldn6methylationtosuppressmigrationandinvasionofbreastcancercells |